Investment Summary

Avista Capital Partners Invests In eMolecules

On March 25, 2021, private equity firm Avista Capital Partners invested in software company eMolecules

Investment Highlights
  • This is Avista Capital Partners’ 1st transaction in the Software sector.
  • This is Avista Capital Partners’ 39th transaction in the United States.
  • This is Avista Capital Partners’ 6th transaction in California.

Investment Summary
Date 2021-03-25
Target eMolecules
Sector Software
Investor(s) Avista Capital Partners
Deal Type Growth Capital
Advisor(s) Robert W. Baird & Co., Inc. (Financial)
Paul Hastings (Legal)

Target

eMolecules

San Diego, California, United States
website
eMolecules provides business intelligence data and integrated ecommerce software for screening compound, chemical building blocks and primary antibody supply chains. eMolecules was founded in 2005 and is based in San Diego, California.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Avista Capital Partners

New York, New York, United States

website

Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.

DEAL STATS #
Overall 48 of 53
Sector (Software) 1 of 1
Type (Growth Capital) 5 of 5
State (California) 6 of 6
Country (United States) 39 of 43
Year (2021) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-12 Cooper Consumer Health

Paris, France

Cooper Consumer Health is an independent OTC drug manufacturer and distributor. It operates a distinctive business model with a unique distribution network and best-in-class sales force accessing all 22,000 pharmacies. Cooper Consumer Health was formed in 2016 and is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-09 Arcadia Consumer Healthcare

Bridgewater, New Jersey, United States

Arcadia Consumer Healthcare is a consumer healthcare company that provides over-the-counter medicines and vitamins, minerals and supplements. Arcadia has been delivering innovative healthcare products to help consumers self-treat their everyday problems. Arcadia Consumer Healthcare is based in Bridgewater, New Jersey.

Sell -
Mergr

Product

Company

Legal